Managing Partner

Erik Lundh

Erik R. Lundh is a co-founder and Managing Partner at Park Square.

He is based in the firm’s California offices and focuses nationally on the Life Sciences, Healthcare, and Healthcare IT industries.

Erik specializes in providing leadership consulting and talent advisory services to clients that are growth oriented in nature. He has more than 27 years of experience in the Life Sciences/healthcare industry and executive search. His clients have included global multinational corporations and early-stage companies alike. Erik’s proficiency in offering counsel and conducting engagements ranging from technical to operational roles stems from his own experience in both scientific and executive-level commercial functions within the Life Sciences industry.

Prior to co-founding Park Square, Erik was Managing Director, Life Sciences at J. Robert Scott, a global retained executive search firm. Previously, Erik was Managing Partner with Heidrick & Struggles and Partner-in-Charge of the firm’s San Francisco office. Earlier, he was a Partner with another leading international executive search firm.

Before entering the search profession, Erik worked as an operator in roles spanning corporate strategy, business development, sales, marketing, and operations. While in industry, Erik held senior operating roles with companies such as Sentigen Holding Corp. (Nasdaq: SGHL), ACLARA BioSciences Inc. (Nasdaq: ACLA), SciQuest, Inc. (Nasdaq: SQST), and Qiagen Inc. (Nasdaq: QGEN).

Erik is an advisor to Spindletop Capital. He holds a bachelor’s degree in biological sciences from Santa Clara University.

Actelion Pharmaceuticals

Senior Vice President, Medical
Head, Regulatory Affairs
Head, Medical Affairs

Affymetrix

Chief Commercial Officer
Senior Vice President, Global Commercial Operations
Senior Vice President, Manufacturing Operations
Vice President, Marketing (2)

Aileron Therapeutics

Chief Executive Officer
Chief Scientific Officer

Akebia Therapeutics

Senior Vice President, Business Development

Alexion Pharmaceuticals

Senior Vice President, Global Clinical Development
Vice President, Commercial Operations
Head, Corporate Communications

Allylix

Vice President, Operations

Arena Pharmaceuticals

Chief Commercial Officer

Ascendis Pharma

Vice President, Global Regulatory Affairs

Aziyo Biologics

President and Chief Operating Officer

Biogen

Senior Vice President, Public Affairs

Bioinnovation Institute

President And Chief Executive Officer

Cadence Pharmaceuticals

Senior Vice President, Corporate Development And Strategy

Cardiome Pharma

Vice President, Manufacturing

Castle Biosciences

Chief Medical Officer

Cellfor

Senior Vice President, Operations

Cequr

Chief Executive Officer

Cidara Therapeutics

Chief Financial Officer

Codexis

Senior Vice President, Strategic And Corporate Development

Cofactor Genomics

Independent Director, Board of Directors

Cognoa

Chief Executive Officer

Complete Genomics

Chief Medical Officer

Conformis

Chief Financial Officer

Contrafect

Head, Investor Relations

Cougar Biotechnology

Non-Executive Director
Chief Financial Officer
Senior Vice President, Business Development

Cubist

Vice President, Investor Relations

Daiichi Sankyo

Executive Director, Clinical Development, Oncology

Dendreon Corporation

Chief Financial Officer
Senior Vice President, Sales And Marketing

Element Science

Vice President, Research And Development

Equity Healthcare

Chief Operating Officer

Exelixis

Vice President, Human Resources

Flx Bio

Chief Operating Officer

Foxhollow Technologies

Chief Medical Officer

Gilead Sciences

Vice President, Marketing
Senior Director, Commercial Strategy (3)

Histogenics Corporation

Chief Executive Officer
Chief Business Officer
Chief Financial Officer

Impossible Foods

Chief Science Officer

Incline Therapeutics

Chief Commercial Officer

Insite Vision

Chief Executive Officer

Institute For Oneworld Health

Chief Executive Officer
Chief Financial Officer

Irvine Scientific

Chief Executive Officer

Jennerex Biotherapeutics

Chief Executive Officer

Johnson & Johnson

Vice President, Global Clinical Development
Global Head, Bioanalysis And Preclinical Pharmacokinetics
Regional Head, Bioanalysis And Preclinical Pharmacokinetics
Regional Vice President, Regulatory Affairs

Joule Biotechnologies

Chief Technology Officer
Senior Vice President, Business Development

KBP Biosciences

Vice President, Clinical Operations

Landec Corporation

Vice President, Global Marketing And Business Development

Lifeline Therapeutics

Chief Executive Officer

Liquidia

Chief Executive Officer

Lithera

Chief Executive Officer

Melinta Therapeutics

Chief Executive Officer

Merck & Co.

Vice President, Translational Medicine

Vice President, Cardiovascular and Metabolic Disease
Head, Computational Biology

Director, BD&L Transactions

Nektar Therapeutics

Chief Medical Officer

Chief Financial Officer

Opus One Winery

General Manager, Asia

Outset Medical

Chief Operating Officer

Vice President, Integrated Supply Chain

Pathway Diagnostics

Chief Executive Officer

Portola Pharmaceuticals

Executive Vice President, Chief Human Resources Officer

Pronai

Chief Technology Officer

Pulmonx

Chief Executive Officer

Puma Biotechnology

Senior Vice President, Clinical Research And Development

Vice President, Clinical Development

Qiagen

Head, Project Management

Qspex

Chief Executive Officer

Recursion Pharmaceuticals

Vice President, Translational

Senior Director, Biology

Reshape Medical

Chief Executive Officer

Rf Surgical

Chief Executive Officer

Rgenix

Chief Executive Officer

Sarepta

Vice President, Global Regulatory Affairs

Satellite Healthcare

Independent Director

Scripps Research Institute

Chief Medical Officer

Simons Foundation/Uam Global

Executive Director

Smart Holograms

Chief Executive Officer
Vice President, Business Development

Solazyme

General Manager, Health Sciences

Somnomed

President, North America
Chief Medical Officer
Vice President, Managed Care

Spindletop Capital

Managing Director

Syndax

Executive Vice President, Corporate Development

Synedgen

General Manager

Synthetic Genomics

Vice President, Operations
Vice President, Renewable Fuels Research And Development

Theranostics Health

Chief Executive Officer

Theravance

Senior Vice President, Clinical And Medical Affairs
Vice President, Human Resources
Vice President, Drug Metabolism And Pharmacokinetics
Vice President, Clinical Development
Head, Quality
Head, Preclinical Safety
Head, Clinical Pharmacology
Director, Clinical Quality

Torrey Pines Institute For Molecular Studies

Chief Financial Officer

Trinetx

Chief Executive Officer

Trius Therapeutics

Chief Commercial Officer

Vatera Healthcare Partners

Chief Financial Officer 

Vical

Senior Vice President, Corporate Development

Zymergen

Vice President, Automation
Vice President, Genome Engineering

Director, Advanced Technologies

Erik's News and Insights

View All
View All